Unió Europea - romanès - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unió Europea - romanès - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

accord healthcare limited - metforminum - compr. elib. prel. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

merck sante s.a.s. - metforminum - comprimate filmate - 1000 mg

Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

merck sante s.a.s. - metforminum - comprimate filmate - 500 mg

Moldàvia - romanès - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

merck sante s.a.s. - metforminum - comprimate filmate - 850 mg

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zentiva s.a. - romania - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zentiva s.a. - romania - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide